Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!

How has the implantable insulin pump market grown over the years?

In the past few years, the market size for implantable insulin pumps has experienced significant growth. The projection indicates an increase from $3.54 billion in 2024 to $3.88 billion in 2025, translating to a compound annual growth rate (CAGR) of 9.7%. The growth witnessed in the historic period is a result of several factors such as, a rise in the occurrence of diabetes, advancements in insulin delivery techniques, growing consciousness regarding the management of diabetes, increased patient demand for convenience, as well as favorable government laws related to diabetes care.

What Is the forecasted market size and growth rate for the implantable insulin pump market?

In the upcoming years, we can expect a significant increase in the implantable insulin pump market, with an anticipated value of $5.57 billion by 2029. This represents an average yearly growth rate of 9.5%. A host of factors contribute to this predicted growth, including an increase in the diabetes patient population, a rising preference for personalized medicine, increased attention to efficient diabetes management, the growing popularity of non-invasive monitoring solutions, and improvements in healthcare infrastructure. Emerging trends influencing this growth are improved insulin management through AI and machine learning, device miniaturization, mobile and cloud-based system integration, the creation of pumps with enhanced safety features, and continual research and innovation.

Get your implantable insulin pump market report here!

https://www.thebusinessresearchcompany.com/report/implantable-insulin-pump-global-market-report

What are the major factors driving growth in the implantable insulin pump market?

The increase in the number of individuals suffering from diabetes is anticipated to boost the expansion of the implantable insulin pump market. Diabetes, a chronic ailment where the body struggles to regulate blood sugar levels due to either insufficient insulin production or ineffective insulin utilization by cells, is escalating. This escalation is influenced by factors like increased obesity rates, unhealthy eating habits, an inactive lifestyle, and an aging population. An implantable insulin pump offers accurate, ongoing insulin delivery, which stabilizes blood sugar levels, decreases the frequency of injections, and enhances the overall management of diabetes and quality of life. As per the report released by Diabetes UK in May 2024, a charity for people with diabetes in the UK, there were over 5.6 million people in the UK with diabetes. The figures for 2022-23 show an increase of 167,822 cases from the previous year. Therefore, the increasing occurrences of diabetes are fuelling the expansion of the implantable insulin pump market.

What key areas define the segmentation of the global implantable insulin pump Market?

The implantable insulin pump market covered in this report is segmented –

1) By Type: Closed-Loop Insulin Pump, Open-Loop Insulin Pump

2) By Application: Type 1 Diabetes, Type 2 Diabetes

3) By End-User: Hospitals, Home-Care

Subsegments:

1) By Closed-Loop Insulin Pump: Fully Automated Closed-Loop Insulin Pump, Hybrid Closed-Loop Insulin Pump, Closed-Loop Insulin Pump with Continuous Glucose Monitoring (CGM), Closed-Loop Insulin Pump with Adaptive Insulin Delivery

2) By Open-Loop Insulin Pump: Manual Open-Loop Insulin Pump, Basal-Bolus Open-Loop Insulin Pump, Smart Open-Loop Insulin Pump, Patch-Style Open-Loop Insulin Pump

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20565&type=smp

What are the top market players propelling the growth of the implantable insulin pump industry?

Major companies operating in the implantable insulin pump market are Sanofi S.A., Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD., CamDiab Ltd.

What are the key trends shaping the future of the implantable insulin pump market?

The implantable insulin pump market is driven by major corporations’ focus on inventing cutting-edge products, such as closed-loop insulin pump systems. These state-of-the-art systems aim to amplify patient outcomes by streamlining insulin delivery according to real-time glucose levels. Using real-time glucose figures to regulate insulin infusion, a closed-loop insulin pump system, also referred to as an artificial pancreas, combines an insulin pump with a continuous glucose monitor and an algorithm. This complex structure helps in regulating blood sugar levels without having to rely on human input. For instance, in March 2022, Medtronic India Pvt. Ltd., a medical device company based in India, introduced the MiniMed 780G system in India. This advanced closed-loop insulin pump system periodically provides basal insulin and correction doses in every five-minute interval, which aids in maintaining stable blood sugar levels. It allows users to set glucose targets as low as 100 mg/dL, thus outshining other innovative hybrid systems in enhancing glucose management. The presence of Bluetooth connectivity means that users and caregivers may view current glucose readings and trends using compatible iOS and Android applications. The system is also designed to be simple for healthcare providers to manage, needing only a few tweaks for it to function optimally.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20565

What regions are dominating the implantable insulin pump market growth?

North America was the largest region in the implantable insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Insulin Pens, Syringes, Pumps And Injectors Opportunities And Strategies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Smart Insulin Pens Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: